Related references
Note: Only part of the references are listed.Whole-genome sequencing of a sporadic primary immunodeficiency cohort
James E. D. Thaventhiran et al.
NATURE (2020)
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
Gillian A. Durham et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
Jatin Sharma et al.
FRONTIERS IN PHARMACOLOGY (2019)
PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations
Peng Zhang et al.
BIOINFORMATICS (2018)
Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry
Paul C. Mayor et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
Charlotte Schwab et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
Lisa R. Forbes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/ 07 prospective clinical trial cohort
Darius Juskevicius et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions
Reiko Takahashi et al.
JOURNAL OF IMMUNOLOGY (2017)
Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus erythematosus
Huixia Wang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
Whole Exome Sequencing of Relapsed/Refractory Patients Expands the Repertoire of Somatic Mutations in Diffuse Large B-Cell Lymphoma
Sylvain Mareschal et al.
GENES CHROMOSOMES & CANCER (2016)
The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects
Bodo Grimbacher et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Suppressive activity of human regulatory T cells is maintained in the presence of TNF
Bruno Zaragoza et al.
NATURE MEDICINE (2016)
The mutation significance cutoff: gene-level thresholds for variant predictions
Yuval Itan et al.
NATURE METHODS (2016)
Loss of B Cells in Patients with Heterozygous Mutations in IKAROS
H. S. Kuehn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3
Emma M. Haapaniemi et al.
BLOOD (2015)
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Joshua D. Milner et al.
BLOOD (2015)
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Sarah E. Flanagan et al.
NATURE GENETICS (2014)
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Hye Sun Kuehn et al.
SCIENCE (2014)
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation
Benedicte Neven et al.
BLOOD (2011)
Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation
Aude Magerus-Chatinet et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A production
Reiko Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
Luyan Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
Frank L. van de Veerdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities
Anja Mottok et al.
BLOOD (2009)
Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6
Anja Mottok et al.
BLOOD (2007)
Multistep pathogenesis of autoimmune disease
Christopher C. Goodnow
CELL (2007)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation
MMW Chong et al.
BLOOD (2005)
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
I Melzner et al.
BLOOD (2005)
Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases
M Fujimoto et al.
INTERNATIONAL IMMUNOLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity
T Hanada et al.
IMMUNITY (2003)
A regulatory role for suppressor of cytokine signaling-1 in Th polarization in vivo
M Fujimoto et al.
INTERNATIONAL IMMUNOLOGY (2002)
Share Paper
